Multicenter phase II randomized controlled trial of S-1 and interferon-alpha combined chemotherapy or S-1 alone in advanced hepatocellular carcinoma with extrahepatic metastasis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Interferon alpha
- Indications Liver cancer
- Focus Therapeutic Use
- 26 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 27 Jul 2007 New trial record.